BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Ooki A, Shinozaki E, Yamaguchi K. Immunotherapy in Colorectal Cancer: Current and Future Strategies. J Anus Rectum Colon 2021;5:11-24. [PMID: 33537496 DOI: 10.23922/jarc.2020-064] [Cited by in Crossref: 1] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Li X, Yuan D, Liu Y, Zhu L, Qin H, Yang Y, Li Y, Yan F, Wang Y. Panax notoginseng saponins prevent colitis-associated colorectal cancer via inhibition IDO1 mediated immune regulation. Chinese Journal of Natural Medicines 2022;20:258-69. [DOI: 10.1016/s1875-5364(22)60179-1] [Reference Citation Analysis]
2 Zhang W, Kong X, Ai B, Wang Z, Wang X, Wang N, Zheng S, Fang Y, Wang J. Research Progresses in Immunological Checkpoint Inhibitors for Breast Cancer Immunotherapy. Front Oncol 2021;11:582664. [PMID: 34631507 DOI: 10.3389/fonc.2021.582664] [Reference Citation Analysis]
3 Tan Y, Lu L, Liang X, Chen Y. Identification of a pyroptosis-related lncRNA risk model for predicting prognosis and immune response in colon adenocarcinoma. World J Surg Oncol 2022;20:118. [PMID: 35413978 DOI: 10.1186/s12957-022-02572-8] [Reference Citation Analysis]
4 Rogers JE, Dasari A. Pharmacotherapy for unresectable metastatic colorectal cancer. Expert Opin Pharmacother 2021;:1-10. [PMID: 34534031 DOI: 10.1080/14656566.2021.1982895] [Reference Citation Analysis]
5 Kim CW, Chon HJ, Kim C. Combination Immunotherapies to Overcome Intrinsic Resistance to Checkpoint Blockade in Microsatellite Stable Colorectal Cancer. Cancers (Basel) 2021;13:4906. [PMID: 34638390 DOI: 10.3390/cancers13194906] [Reference Citation Analysis]
6 Lynch KT, Squeo GC, Kane WJ, Meneveau MO, Petroni G, Olson WC, Chianese-Bullock KA, Slingluff CL Jr, Foley EF, Friel CM. A pilot trial of vaccination with Carcinoembryonic antigen and Her2/neu peptides in advanced colorectal cancer. Int J Cancer 2021. [PMID: 34480368 DOI: 10.1002/ijc.33793] [Reference Citation Analysis]
7 Ooki A, Yamaguchi K. The dawn of precision medicine in diffuse-type gastric cancer. Ther Adv Med Oncol 2022;14:175883592210830. [DOI: 10.1177/17588359221083049] [Reference Citation Analysis]
8 Bateman AC. Immune Checkpoint Inhibitor Therapy in Colorectal Cancer-The Role of Cellular Pathology. Int J Surg Pathol 2021;29:584-91. [PMID: 34142908 DOI: 10.1177/10668969211025844] [Reference Citation Analysis]
9 Tu J, Xu H, Ma L, Li C, Qin W, Chen X, Yi M, Sun L, Liu B, Yuan X. Nintedanib enhances the efficacy of PD-L1 blockade by upregulating MHC-I and PD-L1 expression in tumor cells. Theranostics 2022;12:747-66. [PMID: 34976211 DOI: 10.7150/thno.65828] [Reference Citation Analysis]